Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of QNCX is 7.2 and suggests 117% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell